Teva Pharmaceutical Industries Limited (TEVA) Shares Slip, Investors Watching Closely, Here is Why

Teva Pharmaceutical Industries Limited (NYSE: TEVA) shares fell in early trading yesterday lower trade volume than normal after a number of analysts weighed in on the investing value of the stock with a downgraded rating.

Meanwhile, U.S. stocks edged lower Monday, with major indexes retreating from record levels.

The Dow Jones Industrial Average DJIA, -0.31% fell 48 points, or 0.2%, to 19,916, while the S&P 500 index SPX, -0.29% lost 5 points to 2,272, a drop of 0.2%. The Nasdaq Composite Index COMP, -0.03% rose 4 points to 5,529, a gain of about 0.1%.

Analysts at Wells Fargo & Company downgraded shares of Teva Pharmaceutical Industries Limited (NYSE: TEVA) from to Market Perform in a research note to investors today. With a rating of Market Perform on the stock, Teva Pharmaceutical Industries Limited has a 52-week high of $65.20. As a means of comparison, a number of other analysts have spoken on the company in recent days, and Teva Pharmaceutical Industries Limited has earned a consensus one-year price target of $49.00, higher than the opening price of $35.15. Material and major changes in the company’s procedures, future direction or industry can cause downgrades as the analysts believe that the future prospects for the security have diminished from the initial recommendation.

Yesterday Teva Pharmaceutical Industries Limited (NYSE: TEVA) shares last traded at $35.08, which represents a dip of $0.02 from the previous closing price. Opening at $35.15, they varied from $34.97 and $35.39 throughout the day.

Teva Pharmaceutical Industries Limited (NYSE: TEVA) now has a market cap of 35.61B.

Teva Pharmaceutical Industries Limited (NYSE: TEVA) Average Daily Trading Volume

The stock’s average daily volume is 9,801,120 shares out of a total float 904,923,000 and some 2,956,576 shares crossed the trading desk yesterday, 25 percent below normal. lower than normal. Look for trading volume to pick up in the coming days as investors often use swings in trading volume to identify heavy volume accumulation or distribution by institutional investors.

However, a single day of heavy buy side trading is not enough to assert a trend. As such, market traders will continue to watch for institutional sponsorship as a signal that financial institutions are moving forward.

Institutional sponsorship just refers to ownership of a stock by mutual funds, banks, pension funds and other large institutions.

Professional investors such as these have substantial teams of analysts researching thousands of stocks, so it is good confirmation to see them taking a postion in a stock you are researching.

Teva Pharmaceutical Industries Limited (NYSE: TEVA) Moving Averages

A moving average can also act as support or resistance. In an uptrend a 50-day, 100-day or 200-day moving average may act as a support level, as shown in the figure below.

This is because the average acts like a floor (support), so the price bounces up off of it.

In a downtrend a moving average may act as resistance; like a ceiling, the price hits it and then starts to drop again.

By tracking the activity of these professional investors—and the moving averages they affect—it allows for traders to make more effective decisions on trades.

Trades for Teva Pharmaceutical Industries Limited (NYSE: TEVA) have ranged from $34.57 – 65.2000, and the stock now has a 50-day MA of $36.93 and 200-day MA of $46.08. Today’s last price is 46.19%% below the 52 week high of $65.20.

Earnings growth is an important factor to consider when buying stocks and investors watch for companies that have raised their earnings by at least 25% over the past 3 years.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of the website. Readers should not consider statements made by the author as formal recommendations and should consult their financial adviser before making any investment decisions. To read our full disclosure, please see our terms and conditions page.

Latest News

Leave a Reply